Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_assertion type Assertion NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_head.
- NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_assertion wasGeneratedBy ECO_0000203 NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_provenance.
- NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_assertion wasDerivedFrom befree-20140225 NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_provenance.
- NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_assertion SIO_000772 11318984 NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_provenance.
- NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_assertion evidence source_evidence_literature NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_provenance.
- NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_assertion description "[The alleles DRB1*1501 (36% of HCC patients versus 19% of controls, odds ratio=2.44), DQA1*0102 (42% versus 26%, odds ratio=2.07), and DPB1*0501 (80% versus 63%, odds ratio=2.35) were significantly more common in patients with hepatocellular carcinoma, and DQA1*03 (36% versus 56%, odds ratio=0.53), DQB1*0302 (4.% versus 13%, odds ratio=0.25) and DPB1*0201 (14% versus 29%, odds ratio=0.4) were found at significantly lower frequencies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605893.RACVS9rwAT1MtTIbYlbdwxOnzT3ptp6JabrRqY3IUDvVw130_provenance.